Literature DB >> 15086835

Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.

Hidefumi Shiroshita1, Hidenobu Watanabe, Yoichi Ajioka, Gen Watanabe, Ken Nishikura, Seigo Kitano.   

Abstract

We examined which, and how many, mucin markers are necessary to define the phenotypes of gastric cancers, and re-evaluated the incidence of their mucin phenotypes and whether minute gastric carcinomas arise as unclassified type. Well-differentiated-type minute gastric carcinomas (n = 33) measuring <or=5 mm were examined using human gastric mucin (HGM) and MUC5AC, MUC6 and M-GGMC-1 (or paradoxical concanavalin A type III mucin (Con A)), MUC2 and CD10 stains, and a new method to separate the previous intestinal type into intestinal type and small intestinal type. The phenotypes of carcinomas were classified into gastric, gastrointestinal, intestinal, small intestinal, and unclassified types. MUC5AC or HGM, MUC6, MUC2, and CD10 stains were all necessary to define gastric cancer phenotypes. The incidence of gastric, gastrointestinal, intestinal, small intestinal, and unclassified type was 6%, 49%, 0%, 45%, and 0%, respectively, when the percentage of positive mucin phenotype was set at >0%, and was 33%, 33%, 3%, 30%, and 0%, respectively, when the percentage of positive mucin phenotype was set at >or=10%. Thus, a panel of MUC5AC (or HGM), MUC6, MUC2 and CD10 stains is indispensable for accurately determining the mucin phenotypes of gastric carcinomas, and the above-mentioned classification is important for studying changes in the histological types of well-differentiated-type adenocarcinomas during change to the poorly differentiated type, as well as corresponding genetic abnormalities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086835     DOI: 10.1111/j.1440-1827.2004.01625.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  32 in total

1.  Relationship between clinicopathological features and mucin phenotypes of advanced gastric adenocarcinoma.

Authors:  Fumiaki Toki; Atsushi Takahashi; Ryusuke Aihara; Kyoichi Ogata; Hiroyuki Ando; Tetsuro Ohno; Erito Mochiki; Hiroyuki Kuwano
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

2.  Pyloric gland adenoma arising in Barrett's esophagus with mucin immunohistochemical and molecular cytogenetic evaluation.

Authors:  Ryoji Kushima; Michael Vieth; Ken-Ichi Mukaisho; Rie Sakai; Hidetoshi Okabe; Takanori Hattori; Horst Neuhaus; Franz Borchard; Manfred Stolte
Journal:  Virchows Arch       Date:  2005-04-19       Impact factor: 4.064

3.  Evaluation of mucin expression patterns in gastric borderline (group III) lesions.

Authors:  Hideki Minematsu; Yasuharu Saito; Rie Kakinoki; Akira Andoh; Ryoji Kushima; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

4.  Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma.

Authors:  Tsutomu Namikawa; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

5.  [Barrett's esophagus: analyses from human and experimental animal studies].

Authors:  R Kushima; K-I Mukaisho; S Takemura; H Sugihara; T Hattori; M Vieth
Journal:  Pathologe       Date:  2013-03       Impact factor: 1.011

6.  Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers.

Authors:  Masau Sekiguchi; Ryoji Kushima; Ichiro Oda; Haruhisa Suzuki; Hirokazu Taniguchi; Shigeki Sekine; Takeo Fukagawa; Hitoshi Katai
Journal:  J Gastroenterol       Date:  2014-08-21       Impact factor: 7.527

7.  Mucin phenotype and narrow-band imaging with magnifying endoscopy for differentiated-type mucosal gastric cancer.

Authors:  Masaaki Kobayashi; Manabu Takeuchi; Yoichi Ajioka; Satoru Hashimoto; Akito Sato; Rintaro Narisawa; Yutaka Aoyagi
Journal:  J Gastroenterol       Date:  2011-06-11       Impact factor: 7.527

8.  MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.

Authors:  Jon M Davison; Shane T Ellis; Tyler J Foxwell; James D Luketich; Michael K Gibson; Shih-Fan Kuan; Katie S Nason
Journal:  Hum Pathol       Date:  2013-10-30       Impact factor: 3.466

9.  Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases.

Authors:  Rie Kakinoki; Ryoji Kushima; Akiko Matsubara; Yasuharu Saito; Hidetoshi Okabe; Yoshihide Fujiyama; Takanori Hattori
Journal:  Dig Dis Sci       Date:  2008-08-16       Impact factor: 3.199

10.  Study of clinicopathological factors associated with the occurrence of synchronous multiple gastric carcinomas.

Authors:  Toshikatsu Nitta; Yutaro Egashira; Hiroshi Akutagawa; Go Edagawa; Yoshitaka Kurisu; Eiji Nomura; Nobuhiko Tanigawa; Yuro Shibayama
Journal:  Gastric Cancer       Date:  2009-04-24       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.